Celgene Corp (NASDAQ:CELG)

CAPS Rating: 4 out of 5

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

Recs

0
Player Avatar clarkrl2 (79.86) Submitted: 10/30/2010 10:09:39 PM : Outperform Start Price: $61.50 CELG Score: +1.09

Looking for S&P 500 stocks with a reasonable valuation. I have a 99 target price.

Featured Broker Partners


Advertisement